ReviewExploratory research in clinical and social pharmacy2026
Stakeholders' views of the implementation of pharmacist prescribing in the community pharmacy setting: a mixed-methods systematic review.
Review in Exploratory research in clinical and social pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pharmacist prescribing in community pharmacies is gaining traction globally as a strategy to enhance medication access. However, uptake remains inconsistent, making it essential to understand stakeholder perspectives to identify factors shaping successful implementation. Aim: To synthesise the views, experiences, perceived benefits, concerns, and contextual influences of key stakeholders regarding pharmacist prescribing in community pharmacies across implementation stages. Method: A mixed-methods systematic review using a convergent integrated approach was conducted. Five databases were searched from inception to March 2025. Primary research studies were included where ≥1 key study focus was on stakeholders' views of pharmacist prescribing in community pharmacies. Thematic synthesis was used to generate themes. Results: Five analytical themes explained variation in implementation: (1) support, motivation, and clinical readiness; (2) structural, policy, and organisational conditions shaping feasibility; (3) patient-centred access, continuity, and therapeutic relationships; (4) moral responsibility, risk, and safe practice boundaries; and (5) professional identity, autonomy, and legitimacy. Overall, the literature reflected support for pharmacist prescribing, particularly for low-risk, protocol-driven conditions and collaborative care models, although views varied across stakeholder groups and contexts. Perceived benefits included improved medication access, adherence, convenience, and patient satisfaction. Concerns remained regarding accountability, medico-legal risk, care fragmentation, workload, reimbursement, and commercial conflicts of interest. Confidence, training, interprofessional collaboration, and access to records strongly influenced implementation. Conclusion: Pharmacist prescribing is shaped by interacting individual, organisational and system-level factors. Sustainable implementation requires integrated care models, workforce development, governance frameworks, and supportive policy. This review offers actionable insights for policymakers and healthcare systems seeking to integrate pharmacist prescribing into routine care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.